AMBP - AptarGroup: Shares Are Pumped Up
2024-07-16 13:25:36 ET
Summary
- AptarGroup is a designer and producer of drug delivery solutions and consumer product dispensing solutions.
- The company's revenue and profitability have been improving, but shares are considered expensive compared to similar firms.
- Despite impressive results, AptarGroup is rated a 'hold' due to its relatively expensive stock valuation, and how shares are priced on an absolute basis.
Even though I find a number of companies to be interesting from an operational or business model standpoint, I have to remain principled and only base my ratings on the value that investors are receiving for the price that they are paying. This is a core tenet of wise investing. But it's not always easy. One company that I think is very intriguing but ultimately not a great investment opportunity is AptarGroup ( ATR ). For those not familiar with the business, it operates as a designer and producer of drug delivery solutions and services. In addition to this, it produces a wide array of consumer product dispensing and material science solutions. Examples include the production of nasal drug delivery spray pumps, metered dose inhaler valves, spray and lotion pumps, and more....
AptarGroup: Shares Are Pumped Up